Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthcare & Medical Investment's quarterly Ending Cash Position
increased
from Jan. 2025 (円2,224 Mil) to Jul. 2025 (円2,414 Mil) and
increased
from Jul. 2025 (円2,414 Mil) to Jan. 2026 (円2,657 Mil).
Healthcare & Medical Investment's annual Ending Cash Position
increased
from Jul. 2023 (円3,325 Mil) to Jul. 2024 (円4,110 Mil) and
increased
from Jul. 2024 (円4,110 Mil) to Jul. 2025 (円4,638 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare & Medical Investment Ending Cash Position Chart
Healthcare & Medical Investment Ending Cash Position Calculation
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
What does a Ending Cash Position of 円2,657 Mil mean?
Healthcare & Medical Investment (TSE:3455) has a Ending Cash Position of 円2,657 Mil as of Jan. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Healthcare & Medical Investment and its competitors.
Is Healthcare & Medical Investment's Ending Cash Position too high?
Healthcare & Medical Investment's current Ending Cash Position is 円2,657 Mil. Overall, Healthcare & Medical Investment has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's Ending Cash Position compare to WELL and VTR?
Healthcare & Medical Investment's Ending Cash Position of 円2,657 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a REITs company?
A good Ending Cash Position depends on the REITs industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Healthcare & Medical Investment and its competitors. Healthcare & Medical Investment's current Ending Cash Position is 円2,657 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,557.46, compared to a current price of 円96,300.00 — trading 25.7% below its estimated fair value. The current Ending Cash Position is 円2,657 Mil. Healthcare & Medical Investment's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current Ending Cash Position is 円2,657 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?
Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued.
The current stock price of 円96,300.00 is trading 25.7% below its estimated GF Value™ of 円129,557.46.
GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.
Key valuation signals for TSE:3455:
Ending Cash Position: 円2,657 Mil
GF Value™: 円129,557.46 vs. price of 円96,300.00 (25.7% below fair value)
No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
50GF Score
Get the complete analysis for TSE:3455
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3455 has been successfully added to your 
